This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Sproutly Canada Past Earnings Performance
Past criteria checks 0/6
Key information
76.5%
Earnings growth rate
83.0%
EPS growth rate
| Pharmaceuticals Industry Growth | 7.3% |
| Revenue growth rate | 43.2% |
| Return on equity | n/a |
| Net Margin | -2,583.9% |
| Last Earnings Update | 30 Nov 2021 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Sproutly Canada makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Nov 21 | 1 | -14 | 1 | 0 |
| 31 Aug 21 | 0 | -13 | 1 | 0 |
| 31 May 21 | 1 | -15 | 2 | 0 |
| 28 Feb 21 | 0 | -16 | 2 | 0 |
| 30 Nov 20 | 0 | -59 | 4 | 0 |
| 31 Aug 20 | 1 | -59 | 5 | 0 |
| 31 May 20 | 1 | -61 | 6 | 0 |
| 29 Feb 20 | 1 | -62 | 8 | 0 |
| 30 Nov 19 | 1 | -12 | 10 | 0 |
| 31 Aug 19 | 0 | -12 | 10 | 0 |
| 31 May 19 | 0 | -14 | 9 | 0 |
| 28 Feb 19 | 0 | -13 | 8 | 0 |
| 30 Nov 18 | 0 | -10 | 5 | 0 |
| 31 Aug 18 | 0 | -9 | 3 | 0 |
| 31 May 18 | 0 | -4 | 3 | 0 |
Quality Earnings: 38G is currently unprofitable.
Growing Profit Margin: 38G is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 38G's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare 38G's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 38G is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (18.2%).
Return on Equity
High ROE: 38G's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.